ReviewCureus2025

Omecamtiv Mecarbil in Systolic Heart Failure: Clinical Efficacy and Future Directions of a Novel Myosin-Activating Inotropic Agent.

Mahmoud M Ramadan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.